306 related articles for article (PubMed ID: 25123297)
21. Physician Experiences and Understanding of Genomic Sequencing in Oncology.
Weipert CM; Ryan KA; Everett JN; Yashar BM; Chinnaiyan AM; Scott Roberts J; De Vries R; Zikmund-Fisher BJ; Raymond VM
J Genet Couns; 2018 Feb; 27(1):187-196. PubMed ID: 28840409
[TBL] [Abstract][Full Text] [Related]
22. Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.
Shirdarreh M; Aziza O; Pezo RC; Jerzak KJ; Warner E
Oncologist; 2021 Aug; 26(8):e1359-e1371. PubMed ID: 33823080
[TBL] [Abstract][Full Text] [Related]
23. Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.
Yap TA; Stadler ZK; Stout LA; Schneider BP
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390738. PubMed ID: 37390373
[TBL] [Abstract][Full Text] [Related]
24. Ethical considerations surrounding germline next-generation sequencing of children with cancer.
Johnson LM; Hamilton KV; Valdez JM; Knapp E; Baker JN; Nichols KE
Expert Rev Mol Diagn; 2017 May; 17(5):523-534. PubMed ID: 28399664
[TBL] [Abstract][Full Text] [Related]
25. Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.
Eoh KJ; Kim HM; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
BMC Cancer; 2020 Mar; 20(1):204. PubMed ID: 32164585
[TBL] [Abstract][Full Text] [Related]
26. Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
Ong PY; Poon SL; Tan KT; Putti TC; Ow SGW; Chen SJ; Chen CH; Lee SC
Gynecol Oncol; 2019 Nov; 155(2):275-279. PubMed ID: 31481248
[TBL] [Abstract][Full Text] [Related]
27. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.
Loong HH; Shimizu T; Prawira A; Tan AC; Tran B; Day D; Tan DSP; Ting FIL; Chiu JW; Hui M; Wilson MK; Prasongsook N; Koyama T; Reungwetwattana T; Tan TJ; Heong V; Voon PJ; Park S; Tan IB; Chan SL; Tan DSW
ESMO Open; 2023 Aug; 8(4):101586. PubMed ID: 37356359
[TBL] [Abstract][Full Text] [Related]
28. Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion
Vidula N; Rich TA; Sartor O; Yen J; Hardin A; Nance T; Lilly MB; Nezami MA; Patel SP; Carneiro BA; Fan AC; Brufsky AM; Parker BA; Bridges BB; Agarwal N; Maughan BL; Raymond VM; Fairclough SR; Lanman RB; Bardia A; Cristofanilli M
Clin Cancer Res; 2020 Jun; 26(11):2546-2555. PubMed ID: 32034076
[TBL] [Abstract][Full Text] [Related]
29. Additional germline findings from a tumor profiling program.
Stjepanovic N; Stockley TL; Bedard PL; McCuaig JM; Aronson M; Holter S; Semotiuk K; Leighl NB; Jang R; Krzyzanowska MK; Oza AM; Gupta A; Elser C; Ahmed L; Wang L; Kamel-Reid S; Siu LL; Kim RH
BMC Med Genomics; 2018 Aug; 11(1):65. PubMed ID: 30092803
[TBL] [Abstract][Full Text] [Related]
30. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
32. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
33. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
34.
Chao A; Lin YH; Yang LY; Wu RC; Chang WY; Chang PY; Chang SC; Lin CY; Huang HJ; Lin CT; Chou HH; Huang KG; Kuo WL; Chang TC; Lai CH
J Gynecol Oncol; 2020 May; 31(3):e24. PubMed ID: 31912679
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
36. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
Mody RJ; Wu YM; Lonigro RJ; Cao X; Roychowdhury S; Vats P; Frank KM; Prensner JR; Asangani I; Palanisamy N; Dillman JR; Rabah RM; Kunju LP; Everett J; Raymond VM; Ning Y; Su F; Wang R; Stoffel EM; Innis JW; Roberts JS; Robertson PL; Yanik G; Chamdin A; Connelly JA; Choi S; Harris AC; Kitko C; Rao RJ; Levine JE; Castle VP; Hutchinson RJ; Talpaz M; Robinson DR; Chinnaiyan AM
JAMA; 2015 Sep; 314(9):913-25. PubMed ID: 26325560
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.
Yamamoto Y; Kanai M; Kou T; Sugiyama A; Nakamura E; Miyake H; Yamada T; Nishigaki M; Kondo T; Murakami H; Torishima M; Matsumoto S; Kosugi S; Muto M
J Hum Genet; 2020 Jan; 65(2):125-132. PubMed ID: 31628423
[TBL] [Abstract][Full Text] [Related]
38. Germline and somatic mutation profile in Cancer patients revealed by a medium-sized pan-Cancer panel.
Li Z; Wang H; Zhang Z; Meng X; Liu D; Tang Y
Genomics; 2021 Jul; 113(4):1930-1939. PubMed ID: 33878367
[TBL] [Abstract][Full Text] [Related]
39. Cancer genomics and inherited risk.
Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants.
Stoltze UK; Hagen CM; van Overeem Hansen T; Byrjalsen A; Gerdes AM; Yakimov V; Rasmussen S; Bækvad-Hansen M; Hougaard DM; Schmiegelow K; Hjalgrim H; Wadt K; Bybjerg-Grauholm J
Genome Med; 2023 Mar; 15(1):17. PubMed ID: 36918911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
